Oruka Therapeutics (ORKA) Proxy filing summary

Voting matters and shareholder proposals

• Election of Class II Directors for terms expiring in 2029, with nominees Lawrence Klein and Chris Martin recommended by the board.

• Ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.

• Advisory vote to approve the compensation of named executive officers.

• Provision for other business to be addressed as may properly come before the meeting or any adjournment.

Board of directors and corporate governance

• Board recommends the election of two Class II Directors for five-year terms expiring in 2029.

Executive compensation and say-on-pay

• Advisory vote scheduled to approve the compensation of named executive officers.